Escalated Infliximab Dosing in Hidradenitis Suppurativa: A National Survey of Expert Practice

Adarsh Shidhaye, Nicole Edmonds, Gabrielle Schwartzman, Lindsey Buscemi, R. Hal Flowers

Open source

DOI
10.1111/ijd.70625
Published
2026-08-07
Container
International Journal of Dermatology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ijd.70625,
  title = {Escalated Infliximab Dosing in Hidradenitis Suppurativa: A National Survey of Expert Practice},
  author = {Adarsh Shidhaye and Nicole Edmonds and Gabrielle Schwartzman and Lindsey Buscemi and R. Hal Flowers},
  year = {2026},
  journal = {International Journal of Dermatology},
  doi = {10.1111/ijd.70625},
  url = {https://doi.org/10.1111/ijd.70625}
}

RIS

TY  - JOUR
TI  - Escalated Infliximab Dosing in Hidradenitis Suppurativa: A National Survey of Expert Practice
AU  - Adarsh Shidhaye
AU  - Nicole Edmonds
AU  - Gabrielle Schwartzman
AU  - Lindsey Buscemi
AU  - R. Hal Flowers
PY  - 2026
JO  - International Journal of Dermatology
DO  - 10.1111/ijd.70625
UR  - https://doi.org/10.1111/ijd.70625
ER  - 

APA

Shidhaye, A., Edmonds, N., Schwartzman, G., Buscemi, L., & Flowers, R. H. (2026). Escalated Infliximab Dosing in Hidradenitis Suppurativa: A National Survey of Expert Practice. International Journal of Dermatology. https://doi.org/10.1111/ijd.70625

Source records